Back to search results

Transcutaneous Magnetic Stimulation for Ventricular Tachycardia Storm

This study is testing if Transcutaneous Magnetic Stimulation (TcMS) can help people experiencing Ventricular Tachycardia (VT) Storm. VT Storm means you've had three or more episodes of fast heartbeats (VT) or received shocks from your implanted defibrillator within 24 hours, even while taking heart medication. The study will compare two ways of giving TcMS to a sham (inactive) treatment. You might be able to join if you are 18 or older, have VT Storm, and don't have certain medical conditions like a plan for heart ablation in the next 24 hours or metal in your head or neck. The researchers want to see if TcMS reduces how often you experience VT within 24 hours after treatment. The current recruitment status is unclear.

Study design
This is a three-arm randomized clinical trial with 60 planned participants. It compares two types of Transcutaneous Magnetic Stimulation (TcMS) to a sham stimulation.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 24 hours after randomization to measure the burden of VT.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05599022

Randomized Assessment of TcMS for VT Storm

Recruiting
NAAges 18+InterventionalTreatment
University of Pennsylvania
~60 participants
Updated 2026-04-21 on ClinicalTrials.gov
What's tested:Magnetic Stimulation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
VT Burden (24 hours)
Measured over 24 hours after randomization

Conditions

Ventricular Tachycardia

Explore related trials

Ventricular Tachycardia

NCT05599022

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvaniano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Timothy Markman
[email protected]
215-615-4332
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

≥3 episodes of sustained VT or appropriate ICD therapies within 24 hours despite the use of at least one antiarrhythmic drug

Exclusion

Plan for catheter ablation of VT in the next 24 hours
Pregnancy
Contraindication to TcMS (i.e. implantable ventricular assist device, metal implanted in the head or neck \[except the mouth\], implanted medication pumps, cochlear implant, implanted brain stimulator, ocular implant, history of malignancy in the neck)

What this trial measures

  • VT Burden (24 hours)24 hours after randomization

    Number of episodes of sustained ventricular tachycardia